Form 4: Equifax CEO Mark Begor Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Equifax CEO Mark Begor exercised stock options and sold shares of common stock on February 28, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On February 28, 2024, Equifax CEO Mark W Begor exercised stock options to acquire 58,300 shares of Equifax common stock at a price of $127.37 per share.
- Simultaneously, Begor sold a total of 58,300 shares of Equifax common stock on the same day through multiple transactions at weighted average prices ranging from $264.9673 to $268.5756.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2023.
- Following these transactions, Begor directly owns 108,912 shares of Equifax common stock and indirectly owns 125,943 shares through various grantor retained annuity trusts (GRATs).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports transactions executed under a pre-existing plan. There is no indication of positive or negative implications for the company.
Industry Context
Insider transactions are common and closely monitored, especially those executed under 10b5-1 plans, which are designed to allow insiders to trade without accusations of acting on non-public information. The CEO's actions are typical for executives managing their equity compensation.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units, aligning executive interests with shareholder value.
- Sales under 10b5-1 plans are a standard practice among public company executives to diversify their holdings and manage personal finances.
- The use of GRATs is a common estate planning technique employed by high-net-worth individuals, including corporate executives, to transfer wealth while minimizing gift and estate taxes.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the pre-planned nature of the sales.
Key Dates
| Date | Description |
|---|---|
| 02/22/2022 | Date stock option was exercisable |
| 05/2022 | Creation date of 2-year May 2022 GRAT |
| 2021 | Creation date of 4-Year 2021 GRAT |
| 11/06/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 02/28/2024 | Date of stock option exercise and share sales |
| 02/22/2025 | Expiration date of stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.